Christophe Rochais

2.4k total citations · 1 hit paper
70 papers, 1.8k citations indexed

About

Christophe Rochais is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Christophe Rochais has authored 70 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Organic Chemistry, 35 papers in Pharmacology and 32 papers in Molecular Biology. Recurrent topics in Christophe Rochais's work include Cholinesterase and Neurodegenerative Diseases (27 papers), Computational Drug Discovery Methods (21 papers) and Chemical synthesis and alkaloids (13 papers). Christophe Rochais is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (27 papers), Computational Drug Discovery Methods (21 papers) and Chemical synthesis and alkaloids (13 papers). Christophe Rochais collaborates with scholars based in France, Italy and Egypt. Christophe Rochais's co-authors include Patrick Dallemagne, Ronan Bureau, Jean‐Pierre Jourdan, Serge Mignani, Alban Lepailleur, Amanda Garrido, Thomas Fréret, Michel Boulouard, Jana Sopková‐de Oliveira Santos and Cédric Lecoutey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Christophe Rochais

66 papers receiving 1.7k citations

Hit Papers

Drug repositioning: a brief overview 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drug repositioning: a brief overview
    2020 304 citations Jean‐Pierre Jourdan, Ronan Bureau et al. Journal of Pharmacy and Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Rochais France 22 643 578 561 551 233 70 1.8k
Patrick Dallemagne France 28 996 1.5× 665 1.2× 1.5k 2.6× 596 1.1× 248 1.1× 147 3.0k
Antonio Carrieri Italy 25 827 1.3× 354 0.6× 744 1.3× 284 0.5× 96 0.4× 99 1.8k
Gniewomir Latacz Poland 24 771 1.2× 342 0.6× 625 1.1× 239 0.4× 145 0.6× 128 1.7k
Opa Vajragupta Thailand 22 677 1.1× 354 0.6× 413 0.7× 178 0.3× 269 1.2× 82 1.8k
Hassan Pajouhesh United States 14 966 1.5× 363 0.6× 465 0.8× 331 0.6× 308 1.3× 30 2.1k
Daniel I. Pérez Spain 31 1.4k 2.2× 823 1.4× 597 1.1× 339 0.6× 499 2.1× 83 2.8k
Githa Elizabeth Mathew India 26 443 0.7× 704 1.2× 731 1.3× 271 0.5× 128 0.5× 48 1.7k
Michael S. Malamas United States 27 1.5k 2.3× 610 1.1× 1.2k 2.1× 461 0.8× 294 1.3× 71 3.3k
Philippe Chavatte France 26 1.2k 1.8× 504 0.9× 707 1.3× 207 0.4× 131 0.6× 85 2.5k
Richard Morphy United Kingdom 12 1.3k 2.1× 623 1.1× 932 1.7× 804 1.5× 227 1.0× 16 2.6k

Countries citing papers authored by Christophe Rochais

Since Specialization
Citations

This map shows the geographic impact of Christophe Rochais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Rochais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Rochais more than expected).

Fields of papers citing papers by Christophe Rochais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Rochais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Rochais. The network helps show where Christophe Rochais may publish in the future.

Co-authorship network of co-authors of Christophe Rochais

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Rochais. A scholar is included among the top collaborators of Christophe Rochais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Rochais. Christophe Rochais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lecoutey, Cédric, et al.. (2025). Targeting together cholinesterases and serotonin reuptake against Alzheimer’s disease. Journal of Pharmacy and Pharmacology. 77(10). 1303–1318.
2.
3.
Davis, Audrey, María Valcárcel, Isbaal Ramos, et al.. (2024). Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents. Molecules. 29(2). 515–515. 3 indexed citations
4.
Ramos, Isbaal, María Valcárcel, Achille Gravanis, et al.. (2023). Design, synthesis and biological characterization of novel activators of the TrkB neurotrophin receptor. European Journal of Medicinal Chemistry. 248. 115111–115111. 5 indexed citations
5.
Lecoutey, Cédric, et al.. (2023). Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer’s Disease. Pharmaceutics. 15(10). 2382–2382. 7 indexed citations
6.
Rochais, Christophe, et al.. (2023). C3-Symmetric Ligands in Drug Design: When the Target Controls the Aesthetics of the Drug. Molecules. 28(2). 679–679. 8 indexed citations
7.
8.
Mignani, Serge, et al.. (2022). Advances in prodrug design for Alzheimer’s disease: the state of the art. Expert Opinion on Drug Discovery. 17(4). 325–341. 3 indexed citations
9.
Dallemagne, Patrick, et al.. (2021). Aminothiaindanone as an Accessible Scaffold for a Three-Point Chemical Diversity. Synthesis. 53(20). 3799–3814.
10.
Rochais, Christophe, et al.. (2020). Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges. Journal of Medicinal Chemistry. 63(19). 10705–10725. 65 indexed citations
11.
Jourdan, Jean‐Pierre, Ronan Bureau, Christophe Rochais, & Patrick Dallemagne. (2020). Drug repositioning: a brief overview. Journal of Pharmacy and Pharmacology. 72(9). 1145–1151. 304 indexed citations breakdown →
12.
Groo, Anne‐Claire, Céline Picard, Audrey Davis, et al.. (2020). Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment. Pharmaceutics. 12(3). 251–251. 60 indexed citations
13.
Cimino, Mena, Cédric Lecoutey, Noelia Alonso‐Rodríguez, et al.. (2020). Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis. European Journal of Medicinal Chemistry. 207. 112821–112821. 9 indexed citations
14.
Lecoutey, Cédric, Rémi Legay, Audrey Davis, et al.. (2020). First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease. Molecules. 26(1). 80–80. 16 indexed citations
15.
Dallemagne, Patrick, et al.. (2020). Therapeutic modulators of the serotonin 5-HT 4 receptor: a patent review (2014-present). Expert Opinion on Therapeutic Patents. 30(7). 495–508. 11 indexed citations
16.
Lecoutey, Cédric, Audrey Davis, Marc Since, et al.. (2019). Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease. Molecules. 24(15). 2786–2786. 20 indexed citations
17.
Rochais, Christophe, Cédric Lecoutey, Patrizia Giannoni, et al.. (2019). Donecopride, a Swiss army knife with potential against Alzheimer's disease. British Journal of Pharmacology. 177(9). 1988–2005. 27 indexed citations
18.
Lecoutey, Cédric, Marc Since, Audrey Davis, et al.. (2019). Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease. European Journal of Medicinal Chemistry. 182. 111596–111596. 12 indexed citations
19.
20.
Jourdan, Jean‐Pierre, Marc Since, Laïla El Kihel, et al.. (2017). Benzylphenylpyrrolizinones with Anti‐amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment. ChemMedChem. 12(12). 913–916. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Dallemagne Breakdown of academic impact, for papers by Antonio Carrieri Breakdown of academic impact, for papers by Gniewomir Latacz Breakdown of academic impact, for papers by Opa Vajragupta Breakdown of academic impact, for papers by Hassan Pajouhesh Breakdown of academic impact, for papers by Daniel I. Pérez Breakdown of academic impact, for papers by Githa Elizabeth Mathew Breakdown of academic impact, for papers by Michael S. Malamas Breakdown of academic impact, for papers by Philippe Chavatte Breakdown of academic impact, for papers by Richard Morphy
Rankless by CCL
2026